| First Posted | New Trial Filing | Phase | Status |
|---|---|---|---|
| 2026-05-22 | NCT07602582 A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM… | Phase 3 | Not Yet Recruiting |
| 2026-05-15 | NCT07589595 A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline… | Phase 2 | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT06911944 | Amyloid Lowering for Alzheimer's in Down's With Donanemab Investigation | Down Syndrome (DS) | Not Yet Recruiting |
| Phase 3 | |||
| NCT05026866 | A Donanemab (LY3002813) Study in Participants With Preclinical Alzheimer's Disease… | Alzheimer Disease | Active, Not Recruiting |
| NCT07571161 | Donanemab (LY3002813) Trial in Chinese Participants With Cognitively Unimpaired… | Alzheimer Disease | Not Yet Recruiting |
| NCT07602582 | A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM… | Alzheimer Disease | Not Yet Recruiting |
| NCT05508789 | A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's… | Alzheimer Disease | Active, Not Recruiting |
| Phase 2 | |||
| NCT07167966 | Alzheimer's Tau Platform: Regimen A - AADvac1 | Preclinical Alzheimer's Disease | Not Yet Recruiting |
| NCT07589595 | A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline… | Cognitive Dysfunction | Not Yet Recruiting |